Nordic Nanovector Appoints New Scientific Advisory Board

OSLO, Norway--(BUSINESS WIRE)--Nordic Nanovector ASA (OSE: NANO), a company focusing on the development and commercialization of novel targeted therapeutics in haematology and oncology, announces the formation of a new Scientific Advisory Board (SAB). The SAB includes experts in haematology-oncology and cancer drug development from leading academic/research institutions in the US and Europe.

Help employers find you! Check out all the jobs and post your resume.